We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




CKD May Occur Before Diabetes Diagnosis

By LabMedica International staff writers
Posted on 28 Mar 2018
Doctors have long known that patients with diabetes are at risk for kidney disease, and while chronic kidney disease (CKD) is regularly evaluated among patients with diabetes, kidney function may be significantly impaired before diabetes is diagnosed.

Approximately 10% of the general population in the USA, more than 20 million people, has chronic kidney disease (CKD), and this condition is especially prevalent among patients with diabetes mellitus (DM). More...
Specifically, an estimated one-third of adults with DM have CKD, and DM is the leading cause of CKD and end stage renal disease.

Scientists working with the University of Tennessee Health Science Center (Memphis, TN, USA) assessed the risk of kidney damage from undiagnosed diabetes, and looked at data on 36,794 veterans who were diagnosed with diabetes between 2003 and 2013. They found that 31.6% of these veterans had evidence of CKD prior to the diabetes diagnosis, based on estimated glomerular filtration rate (eGFR) and urine-albumin-creatine ratios, two common measures of kidney function. Veterans with higher age, hemoglobin A1C, blood pressure, and body mass index (BMI) also had a greater risk of CKD. All of these factors are themselves risk factors for diabetes. Those with cerebrovascular disease, congestive heart failure, or peripheral artery disease, conditions that are frequently seen alongside diabetes had higher kidney disease risk as well.

The study also revealed disparities in the rates of CKD based on race. Asian Americans and African Americans had higher rates of chronic kidney disease than whites. However, the proportion of patients who were minorities decreased as disease severity increased. The results suggest that kidney damage often occurs before diabetes is diagnosed. The authors propose two possible reasons for this early kidney damage: Type 2 diabetes can be undiagnosed for a long time, meaning the kidneys are being damaged without the patient or doctors being aware, or, kidney damage could come from other conditions common in the population at risk for diabetes. The results highlight an opportunity for broadening screening among patients with increased risk of CKD. More screening of at-risk populations could lead to earlier identification of diabetes, which could in turn prevent organ damage.

Csaba P. Kovesdy, MD, FASN, a professor of Medical Nephrology and senior author of the study, said, “Chronic kidney disease is silent, so patients can develop even advanced stages of chronic kidney disease before noticing anything. The only way to detect it in most affected individuals is through laboratory measurement, i.e., serum creatinine and urine albumin. Serum creatinine is measured very frequently among veterans, but an abnormal value would only diagnose stage 3 and above of chronic kidney disease. Urine albumin screening would be a way to identify early stages, but the use of this screening test is mostly limited to diabetics.” The study was published on February 9, 2018, in the journal Public Library of Science ONE.

Related Links:
University of Tennessee Health Science Center


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Automated Clinical Chemistry Analyzer
Envoy 500+
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.